Chemical Addiction: Understanding Substance Use Disorder and Its Medical Basis

Definition

Substance Use Disorder (SUD) (DSM-5) is a chronic, relapsing brain disease characterized by impaired control, social impairment, risky use, and pharmacologic criteria (tolerance, withdrawal). Inhalant Use Disorder (sniffing/huffing volatile chemicals: solvents, aerosols, gases, nitrites) is a recognized SUD category.

Neurobiology

  • Chronic inhalant use → dopamine dysregulation in reward circuit (NAc, VTA), glutamate/GABA imbalance, white matter damage (myelin dissolution by lipophilic solvents), cerebellar atrophy.
  • Acute: CNS depression, euphoria, disinhibition, hallucinations.
  • Chronic: Cognitive impairment, neuropathy, cardiomyopathy, hepatotoxicity, renal tubular acidosis, bone marrow suppression.

Treatment

  • Detoxification: Supportive; no specific antidote.
  • Behavioral: CBT, contingency management, motivational interviewing, family therapy.
  • Medication: None FDA-approved for inhalants; treat comorbidities (depression, anxiety).
  • Support: 12-step, peer recovery, residential if severe.

Key Message

Inhalant addiction is a legitimate medical disorder requiring compassionate, evidence-based care. Early intervention prevents irreversible neurologic damage.

Drug Addiction - Related Articles